Cytokinetics
CYTK
#2440
Rank
A$10.66 B
Marketcap
A$76.58
Share price
-1.32%
Change (1 day)
-23.29%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): A-$8.79

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is A-$9.11. In 2025 the company made an earnings per share (EPS) of A-$9.85 a decrease over its 2024 EPS that were of A-$7.93.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$8.79-10.69%
2025A-$9.8524.14%
2024A-$7.93-3.49%
2023A-$8.2228.24%
2022A-$6.4150.18%
2021A-$4.2740.8%
2020A-$3.03
2018A-$2.94-24.12%
2017A-$3.88-776.32%
2016A$0.57-139.18%
2015A-$1.46125.58%
2014A-$0.65-67.67%
2013A-$2.01-44.58%
2012A-$3.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$26.21-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A-$52.39 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.91-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A-$75.87 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A-$1.73-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA